Indivior Pharmaceuticals Inc.
XNAS:INDV
| Market Cap (Intraday) | 4.97B |
| Current PE | 13.99 |
| Forward PE | 9.24 |
| 2yr Forward PE | 8.44 |
| 10-Day MA | $38.74 |
| 50-Day MA | $39.49 |
| 200-Day MA | $35.15 |
Indivior Plc Stock, XNAS:INDV
10710 Midlothian Turnpike, Suite 125, North Chesterfield, Virginia 23235
United Kingdom
Phone: +44.1753.217800
Number of Employees: 1051
Description
Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.